Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System.
about
Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C InfectionsIncident Infection and Resistance Mutation Analysis of Dried Blood Spots Collected in a Field Study of HIV Risk Groups, 2007-2010Beyond surveillance: a role for respondent-driven sampling in implementation science.Evaluating respondent-driven sampling in a major metropolitan area: Comparing injection drug users in the 2005 Seattle area national HIV behavioral surveillance system survey with participants in the RAVEN and Kiwi studiesMental health in HIV seronegative and seropositive IDUs in South FloridaAssessing respondent-driven sampling.Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco.Challenges to recruiting population representative samples of female sex workers in China using Respondent Driven Sampling.Subpopulations of illicit drug users reached by targeted street outreach and respondent-driven sampling strategies: implications for research and public health practiceUnderstanding recruitment: outcomes associated with alternate methods for seed selection in respondent driven sampling.Individual, study, and neighborhood level characteristics associated with peer recruitment of young illicit drug users in New York City: optimizing respondent driven samplingSpatial, temporal and relational patterns in respondent-driven sampling: evidence from a social network study of rural drug users.Assessing the geographic coverage and spatial clustering of illicit drug users recruited through respondent-driven sampling in New York City.Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance SystemHIV behavioral surveillance in the U.S.: a conceptual frameworkRespondent-driven sampling to recruit young adult non-medical users of pharmaceutical opioids: problems and solutions.Factors Associated with Low Levels of HIV Testing among Men Who Have Sex with Men (MSM) in Brazil.Sexual risk and HIV infection among drug users in New York City: a pilot study.Network Characteristics of People Who Inject Drugs Within a New HIV Epidemic Following Austerity in Athens, Greece.Characteristics and health service utilization in two samples of young injection drug users recruited using direct and referral methods in San Francisco, CaliforniaEpidemiology of human immunodeficiency virus in the United StatesSampling Males Who Inject Drugs in Haiphong, Vietnam: Comparison of Time-Location and Respondent-Driven Sampling Methods.Evaluating consistency in repeat surveys of injection drug users recruited by respondent-driven sampling in the Seattle area: results from the NHBS-IDU1 and NHBS-IDU2 surveys.Variations in patterns of sexual risk behavior among Seattle-area MSM based on their HIV status, the HIV status of their partner and partner typeEstimating design effect and calculating sample size for respondent-driven sampling studies of injection drug users in the United States.Assessing the assumptions of respondent-driven sampling in the national HIV Behavioral Surveillance System among injecting drug users.Piloting a system for behavioral surveillance among heterosexuals at increased risk of HIV in the United States.Developing a Web-Based HIV Behavioral Surveillance Pilot Project Among Men Who Have Sex with Men.Estimating the Size of the MSM Population in Metro Vancouver, Canada, Using Multiple Methods and Diverse Data Sources.A comparison of respondent-driven and venue-based sampling of female sex workers in Liuzhou, ChinaReadjustment of Urban Veterans: A Mental Health and Substance Use Profile of Iraq and Afghanistan Veterans in Higher EducationRacialized risk environments in a large sample of people who inject drugs in the United States.Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic.Differing HIV risks and prevention needs among men and women injection drug users (IDU) in the District of Columbia.Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing.Prevalence and correlates of former injection drug use among young noninjecting heroin users in Chicago.Diagnostics for Respondent-driven SamplingRespondent-driven sampling as Markov chain Monte CarloThe role of formative research in the National HIV Behavioral Surveillance System.Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009
P2860
Q28548643-50F62A91-7F8B-4ACE-ADB6-1318CFD57E57Q28552613-D1E02641-485D-4B97-A379-68F6B825F27EQ30432413-8E6D3B4D-F6B3-44EE-91A5-2719F2A4DFFCQ33637683-44FD14D2-89DE-44E2-AC0F-09E843112B5CQ33751012-4BCC3A85-E6A5-46FE-8233-13294AA1D7F9Q33859361-D27C56E1-C00A-40DA-96DF-FD1C2944C6EEQ34117952-C6C51AF0-D57A-4A0A-A5AE-16B7B8CDE4AAQ34429242-6650D712-036A-4938-9269-289F2A9C279FQ34708151-36C07A26-002F-4F11-A581-ECFBB4E7F404Q34831763-3CA661E2-709D-4160-B96C-D7549C9358B3Q35209565-F0045053-D61D-4302-91B9-D37863748D74Q35541751-885E6262-E124-4C24-91BD-296EFBE798B7Q35543311-6EA71616-91E8-456F-A3BE-CDE56FBF5569Q35648785-4B6B8ED8-7120-4393-9E52-B54FF2DE9A0DQ35648791-9B8B7915-D1C0-4F47-BE66-981FFF130DC5Q35667147-3E0F5FB5-7F5D-416B-BED8-93E2786FB827Q35670545-2F41D42F-65FF-4363-AF90-1515745F5BD3Q35690853-343247D2-199A-429D-82B4-EDDDAB5C8E30Q35795332-37BA396B-8526-4D03-ADE6-8B86FA0645E0Q35900606-092F194C-8340-481D-BD20-FE54BFB601C4Q35913181-2F1CD0CD-2122-4E40-9892-8FA8ECF006BBQ35916041-03DD3EE0-9BAC-41C1-9C07-F53F64F0E731Q35918689-0F7EF935-26C0-492B-BB77-23E988DF5CB4Q35942442-329EDCDD-8B57-471A-A7F4-F7866EEA1F8BQ36056824-894432FB-225A-49CD-BB7C-92519CDE9899Q36291591-0DEE5703-8179-4C18-9705-F2EF89AC485BQ36291612-6C136431-C5CA-4A2E-8E87-C8DA404A0156Q36328737-2474CAE1-2099-437B-A328-FD37BFBCF3BEQ36409955-8814F4B3-E984-4B05-8004-4BF73BE0F150Q36440485-60079A51-77C1-41B9-B55F-5A4DA269C3E9Q36455903-8C964B41-4A7F-4AA6-BE2C-EA1CDCE848ABQ36471364-FF45D12A-8A7E-4D12-BEFF-C3BDC45363E2Q36499522-952D2587-D2D3-4B1D-B2E9-92C873946D37Q36629330-2AD01174-C875-4F6D-B6A0-6EC884258B15Q36701912-08C14544-5DA0-41FF-AA17-B0E1F4DCF35CQ36784841-FB275A9B-68C1-45BD-9D25-76635E9DD244Q36927238-149EFA0F-20CF-4B0B-BF93-112ADAC0D3B3Q36934871-01701174-482D-4C8E-A775-C5414D516C40Q37015078-B493FB2C-0F51-4A1F-9C5A-4A54B208B06EQ37040594-BB904D4B-A6E0-491B-947F-B142DACE6A47
P2860
Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Developing an HIV behavioral s ...... ehavioral Surveillance System.
@ast
Developing an HIV behavioral s ...... ehavioral Surveillance System.
@en
type
label
Developing an HIV behavioral s ...... ehavioral Surveillance System.
@ast
Developing an HIV behavioral s ...... ehavioral Surveillance System.
@en
prefLabel
Developing an HIV behavioral s ...... ehavioral Surveillance System.
@ast
Developing an HIV behavioral s ...... ehavioral Surveillance System.
@en
P2093
P2860
P1476
Developing an HIV behavioral s ...... ehavioral Surveillance System.
@en
P2093
Abu S Abdul-Quader
Amy Lansky
Lillian S Lin
Melissa Cribbin
Richard S Garfein
Teresa J Finlayson
Tricia Hall
P2860
P356
10.1177/00333549071220S108
P478
122 Suppl 1
P577
2007-01-01T00:00:00Z